Literature DB >> 6092432

Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis.

S Takahashi, Y Nagano.   

Abstract

A rapid and simple plasmid isolation procedure was developed for the epidemiological analysis of plasmid-mediated antimicrobial resistance. By this method, plasmid DNAs ranging in molecular weight between 2.0 and 122 X 10(6) could be detected. Various bacteria, such as strains of the family Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus, could be analyzed. The plasmid DNA obtained could be directly used for restriction endonuclease analysis without further purification. In addition, this method made it possible to analyze several cultures at the same time.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6092432      PMCID： PMC271394          DOI： 10.1128/jcm.20.4.608-613.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Studies on the cleavage of bacteriophage lambda DNA with EcoRI Restriction endonuclease.

Authors:  M Thomas; R W Davis
Journal:  J Mol Biol       Date:  1975-01-25       Impact factor: 5.469

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid.

Authors:  E M Lederberg; S N Cohen
Journal:  J Bacteriol       Date:  1974-09       Impact factor: 3.490

4.  Circular DNA forms of colicinogenic factors E1, E2 and E3 from Escherichia coli.

Authors:  M Bazaral; D R Helinski
Journal:  J Mol Biol       Date:  1968-09-14       Impact factor: 5.469

5.  Molecular analysis of R-factors from multiresistant nosocomial isolates.

Authors:  L S Tompkins; J J Plorde; S Falkow
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

7.  Characterization of chloramphenicol-resistant Haemophilus influenzae.

Authors:  M C Roberts; C D Swenson; L M Owens; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections.

Authors:  P L Sadowski; B C Peterson; D N Gerding; P P Cleary
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

9.  Dissemination of an antibiotic resistance plasmid in hospital patient flora.

Authors:  T F O'Brien; D G Ross; M A Guzman; A A Medeiros; R W Hedges; D Botstein
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

10.  Physical and topological properties of circular DNA.

Authors:  J Vinograd; J Lebowitz
Journal:  J Gen Physiol       Date:  1966-07       Impact factor: 4.086
View more
  95 in total

1.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermannii.

Authors:  Anne Beauchef-Havard; Guillaume Arlet; Valerie Gautier; Roger Labia; Patrick Grimont; Alain Philippon
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

3.  Rapid plasmid DNA isolation from mucoid gram-negative bacteria.

Authors:  P Domenico; J L Marx; P E Schoch; B A Cunha
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

4.  Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.

Authors:  G Arlet; M J Sanson-le Pors; M Rouveau; G Fournier; O Marie; B Schlemmer; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

5.  qnrVC-like gene located in a novel complex class 1 integron harboring the ISCR1 element in an Aeromonas punctata strain from an aquatic environment in Shandong Province, China.

Authors:  Ruirui Xia; Xianhu Guo; Yuzhen Zhang; Hai Xu
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

6.  High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.

Authors:  L B Rice; L L Carias; A M Hujer; M Bonafede; R Hutton; C Hoyen; R A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

7.  High genetic homology between plasmids of human and animal origins conferring resistance to the aminoglycosides gentamicin and apramycin.

Authors:  E Chaslus-Dancla; P Pohl; M Meurisse; M Marin; J P Lafont
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

8.  Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazilian purpuric fever.

Authors:  D J Brenner; L W Mayer; G M Carlone; L H Harrison; W F Bibb; M C Brandileone; F O Sottnek; K Irino; M W Reeves; J M Swenson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

9.  National prevalence of resistance to third-generation cephalosporins in Escherichia coli isolates from layer flocks in France.

Authors:  Claire Chauvin; Laetitia Le Devendec; Eric Jouy; Maena Le Cornec; Sylvie Francart; Corinne Marois-Créhan; Isabelle Kempf
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  Gentamicin resistance in clinical strains of Enterobacteriaceae associated with reduced gentamicin uptake.

Authors:  K Adwan; N Abu-Hasan
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.